| pubmed-article:7910103 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7910103 | lifeskim:mentions | umls-concept:C0018038 | lld:lifeskim |
| pubmed-article:7910103 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:7910103 | lifeskim:mentions | umls-concept:C1517880 | lld:lifeskim |
| pubmed-article:7910103 | lifeskim:mentions | umls-concept:C0005456 | lld:lifeskim |
| pubmed-article:7910103 | lifeskim:mentions | umls-concept:C0037775 | lld:lifeskim |
| pubmed-article:7910103 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:7910103 | lifeskim:mentions | umls-concept:C0392762 | lld:lifeskim |
| pubmed-article:7910103 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:7910103 | pubmed:dateCreated | 1994-6-16 | lld:pubmed |
| pubmed-article:7910103 | pubmed:abstractText | Goldfish brain is a widely used model system for the study of the mechanisms involved in neuronal regeneration and synaptic plasticity. Because of the proposed role of glutamate receptors in these processes we have investigated the anatomical localisations of [3H]AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate), [3H]kainate, [3H]CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) and [3H]L-glutamate binding sites in horizontal and sagittal sections. Binding sites for [3H]L-glutamate were the most widespread and both NMDA (N-methyl-D-aspartate) and non-NMDA sensitive components were detected. The density of [3H]kainate binding was very high in the cerebellum compared to other regions and in comparison with the other radioligands used. Conversely, relatively low amounts of [3H]AMPA binding were present with the telencephalon being the most densely labelled structure. [3H]CNQX binding was most densely localised in the tectum with the cerebellum also possessing high binding. In addition, there was a small population of [3H]CNQX binding sites located in the telencephalon and lobus vagi that appeared insensitive to AMPA and kainate. | lld:pubmed |
| pubmed-article:7910103 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7910103 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7910103 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7910103 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7910103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7910103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7910103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7910103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7910103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7910103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7910103 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7910103 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:7910103 | pubmed:issn | 0006-8993 | lld:pubmed |
| pubmed-article:7910103 | pubmed:author | pubmed-author:BarnesJ MJM | lld:pubmed |
| pubmed-article:7910103 | pubmed:author | pubmed-author:HenleyJ MJM | lld:pubmed |
| pubmed-article:7910103 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7910103 | pubmed:day | 21 | lld:pubmed |
| pubmed-article:7910103 | pubmed:volume | 637 | lld:pubmed |
| pubmed-article:7910103 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7910103 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7910103 | pubmed:pagination | 323-7 | lld:pubmed |
| pubmed-article:7910103 | pubmed:dateRevised | 2009-9-29 | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:meshHeading | pubmed-meshheading:7910103-... | lld:pubmed |
| pubmed-article:7910103 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7910103 | pubmed:articleTitle | Quantitative analysis of the distributions of glutamatergic ligand binding sites in goldfish brain. | lld:pubmed |
| pubmed-article:7910103 | pubmed:affiliation | Department of Pharmacology, Medical School, University of Birmingham, Edgbaston, UK. | lld:pubmed |
| pubmed-article:7910103 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7910103 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
